These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 22543547)

  • 1. Associations between subjective overactive bladder symptoms and objective parameters on bladder diary and filling cystometry.
    Daan NM; Schweitzer KJ; van der Vaart CH
    Int Urogynecol J; 2012 Nov; 23(11):1619-24. PubMed ID: 22543547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between overactive bladder symptoms and objective parameters from bladder diary and filling cystometry.
    van Brummen HJ; Heintz AP; van der Vaart CH
    Neurourol Urodyn; 2004; 23(1):38-42. PubMed ID: 14694455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the elements of overactive bladder: questions raised by the EPIC study.
    Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
    BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and urodynamic impact of detrusor overactivity in women with overactive bladder.
    Jiménez-Cidre MA; López-Fando L; Mora AM;
    Actas Urol Esp (Engl Ed); 2019 Jun; 43(5):221-227. PubMed ID: 30862379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and urodynamic differences among women with overactive bladder according to the presence of detrusor overactivity.
    Jeong SJ; Lee SC; Jeong CW; Hong SK; Byun SS; Lee SE
    Int Urogynecol J; 2013 Feb; 24(2):255-61. PubMed ID: 22588142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of bladder diary with urinary perception to assess overactive bladder symptoms in community-dwelling women.
    Honjo H; Kawauchi A; Ukimura O; Nakao M; Kitakoji H; Miki T
    Neurourol Urodyn; 2009; 28(8):982-5. PubMed ID: 19267392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fesoterodine for the Treatment of Nocturnal Urgency in Patients with Overactive Bladder Syndrome: An Analysis of Responders and Nonresponders.
    Khusid JA; Weiss JP; Carlsson MO; Mangan EK
    J Urol; 2017 Nov; 198(5):1119-1123. PubMed ID: 28479240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are patients with bladder oversensitivity different from those with urodynamically proven detrusor overactivity in female overactive bladder syndrome?
    Chen SL; Ng SC; Huang YH; Chen GD
    J Chin Med Assoc; 2017 Oct; 80(10):644-650. PubMed ID: 28757173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ambulatory urodynamic monitoring of women with overactive bladder syndrome during single voiding cycle.
    Dokmeci F; Cetinkaya SE; Seval MM; Dai O
    Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():126-131. PubMed ID: 28355584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of solifenacin on diary-recorded and patient-reported urgency in patients with severe overactive bladder (OAB) symptoms.
    Serels SR; Toglia MR; Forero-Schwanhaeuser S; He W
    Curr Med Res Opin; 2010 Oct; 26(10):2277-85. PubMed ID: 20707767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of overactive bladder influenced by methods of clinical assessment--micturition diary vs. urodynamics].
    Skorupski P; Tomaszewski J; Adamiak A; Jankiewicz K; Rechberger T
    Ginekol Pol; 2003 Sep; 74(9):1018-22. PubMed ID: 14674162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In women with urinary incontinence how necessary is cystometry?
    Saleem A
    J Pak Med Assoc; 2010 May; 60(5):356-9. PubMed ID: 20527606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can botox improve night-time overactive bladder symptoms in women?
    Miotla P; Cartwright R; Futyma K; Bogusiewicz M; Skorupska K; Winkler I; Rechberger T
    Neurourol Urodyn; 2017 Mar; 36(3):648-652. PubMed ID: 26915654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the International Consultation on Incontinence Questionnaires Bladder Diary in Men Seeking therapy for Lower Urinary Tract Symptoms.
    Ito H; Abrams P; Lewis AL; Young GJ; Blair PS; Cotterill N; Lane JA; Drake MJ
    Eur Urol Focus; 2022 Jan; 8(1):66-74. PubMed ID: 35027329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urodynamic findings in women with refractory overactive bladder symptoms.
    Al-Zahrani AA; Gajewski J
    Int J Urol; 2016 Jan; 23(1):75-9. PubMed ID: 26417863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Considering non-bladder aetiologies of overactive bladder: a functional neuroimaging study.
    Walter M; Leitner L; Betschart C; Engeler DS; Freund P; Kessler TM; Kollias S; Liechti MD; Scheiner DA; Michels L; Mehnert U
    BJU Int; 2021 Nov; 128(5):586-597. PubMed ID: 33547746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in Urodynamic Parameters Between Women With Interstitial Cystitis and/or Bladder Pain Syndrome and Severe Overactive Bladder.
    Shim JS; Kang SG; Park JY; Bae JH; Kang SH; Park HS; Moon du G; Cheon J; Lee JG; Kim JJ; Oh MM
    Urology; 2016 Aug; 94():64-9. PubMed ID: 27130264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overactive bladder is not only overactive but also hypersensitive.
    Lee SR; Kim HJ; Kim A; Kim JH
    Urology; 2010 May; 75(5):1053-9. PubMed ID: 20092879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease.
    Kabay S; Canbaz Kabay S; Cetiner M; Mestan E; Sevim M; Ayas S; Ozden H; Ozisik Karaman H
    Urology; 2016 Jan; 87():76-81. PubMed ID: 26436213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of the Overactive Bladder Symptom Score, and the Voiding Diary and Urodynamic Parameters in Patients with Overactive Bladder Syndrome.
    Song M; Chun JY; Yoo DS; Han JY; Choo MS
    Low Urin Tract Symptoms; 2014 Sep; 6(3):180-4. PubMed ID: 26663602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.